Quick Answer
ATOSSA THERAPEUTICS, INC. reported Stockholders Equity of $39.35 million for fiscal year 2025.
ATOSSA THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $39.35M | -44.9% |
| 2024 | $71.48M | -21.5% |
| 2023 | $91.02M | -22.8% |
| 2022 | $117.96M | -14.6% |
| 2021 | $138.14M | +408.5% |
| 2020 | $27.17M | +106.5% |
| 2019 | $13.16M | +49.4% |
| 2018 | $8.81M | +26.9% |
| 2017 | $6.94M | +124.0% |
| 2016 | $3.10M | -17.2% |
| 2015 | $3.74M | -60.6% |
| 2014 | $9.50M | -10.4% |
| 2013 | $10.60M | +104.8% |
| 2012 | $5.18M | +231.8% |
| 2011 | $1.56M | +283.1% |
| 2010 | -$851.9K | -2788.7% |
| 2009 | $31.7K | -41.3% |
| 2009 | $54.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $49.79M | -32.4% | -13.7% |
| June 30, 2025 | $57.70M | -28.0% | -11.7% |
| March 31, 2025 | $65.32M | -23.8% | -8.6% |
| December 31, 2024 | $71.48M | -21.5% | -3.0% |
| September 30, 2024 | $73.68M | -25.0% | -8.1% |
| June 30, 2024 | $80.16M | -23.6% | -6.5% |
| March 31, 2024 | $85.76M | -24.3% | -5.8% |
| December 31, 2023 | $91.02M | -22.8% | -7.4% |
- ATOSSA THERAPEUTICS, INC. showed a decrease of -44.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, ATOSSA THERAPEUTICS, INC.’s stockholders equity has grown by 72775.9% (from $54.0 thousand to $39.35 million).
- The most recent figure is from ATOSSA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: